showed that the simultaneous neutralization of IL‐13 and IL‐17 protected mice from eosinophilia, mucus hyperplasia and airway hyperreactivity, and subsequently abolished the neutrophilic inflammation in asthma. This evidence concerns the gene IL13 and asthma.